Related Experiment Video

Updated: May 31, 2026

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue
11:22

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

Characterization of pediatric liver lesions with gadoxetate disodium

Arthur B Meyers1, Alexander J Towbin, Suraj Serai

  • 1Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnett Ave., Cincinnati, OH 45229-3039, USA.

Pediatric Radiology
|June 25, 2011
PubMed

Insights

Gadoxetate disodium (Gd-EOB-DTPA), a hepatobiliary MRI contrast agent, shows promise for diagnosing pediatric liver masses. This study details a pediatric MRI protocol and lesion appearance using this agent.

Area of Science:

  • Pediatric Radiology
  • Hepatobiliary Imaging
  • Contrast-Enhanced MRI

Background:

  • Gadoxetate disodium (Gd-EOB-DTPA) is a hepatobiliary MRI contrast agent increasingly used in adults.
  • Limited data exists on its application in pediatric liver imaging.
  • Characterizing pediatric liver masses remains a diagnostic challenge.

Purpose of the Study:

  • To describe a standardized pediatric MRI protocol utilizing Gd-EOB-DTPA.
  • To illustrate the imaging appearance of pediatric liver lesions with Gd-EOB-DTPA.
  • To evaluate the potential of Gd-EOB-DTPA in improving pediatric liver mass characterization.

Main Methods:

  • Development and implementation of a specific pediatric MRI protocol.
  • Administration of Gd-EOB-DTPA to pediatric patients with liver lesions.
  • Analysis of lesion enhancement patterns and diagnostic accuracy.

Main Results:

  • Detailed description of the pediatric Gd-EOB-DTPA MRI protocol.
  • Illustrative examples of various pediatric liver lesions imaged with Gd-EOB-DTPA.
  • Demonstration of Gd-EOB-DTPA's utility in differentiating lesion types.

Conclusions:

  • Gd-EOB-DTPA can be effectively utilized in pediatric liver MRI.
  • This hepatocyte-specific agent enhances the characterization of pediatric liver masses.
  • Further research can establish Gd-EOB-DTPA as a valuable tool for diagnosing pediatric liver lesions.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is covered...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...